Collectively, MALAT1 and miR-382-3p are present in serum-Exos of T2DM mice, and AE can increase the expression of MALAT1 in mouse serum-Exos, thereby competitively inhibiting miR-382-3p expression. This evidence concerns the gene MALAT1 and type 2 diabetes mellitus.